Find verified Ixazomib citrate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Ixazomib citrate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Ixazomib citrate API.
Alternate Names: UNII-46CWK97Z3K, 46CWK97Z3K, s4432, AKOS030632768
CAS No: 1239908-20-3
PubChem CID: 56844015
Mol Formula: C20H23BCl2N2O9
Mol Weight: 517.1 g/mol
IUPAC Name: 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
API Description: Ixazomib Citrate is the citrate salt form of ixazomib, an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated.
